BioVaxys Technology Corp. (CSE:BIOV)
Canada · Delayed Price · Currency is CAD 0.0700
+0.0100 (16.67%)
May 5, 2026, 3:55 PM EST
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 3.09 million as of May 21, 2026. Its market cap has decreased by -80.75% in one year.
Market Cap
3.09M
Enterprise Value
3.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 3.09M, a decrease of -88.59%. That is a compound annual growth rate of -32.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 3.09M | -68.18% |
| Dec 31, 2025 | 9.70M | -41.13% |
| Dec 31, 2024 | 16.48M | 127.10% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptose Biosciences | 5.95M |
| PharmaTher Holdings | 5.92M |
| Restart Life Sciences | 5.64M |
| Kane Biotech | 5.46M |
| MYND Life Sciences | 5.22M |
| Doseology Sciences | 3.44M |
| Rakovina Therapeutics | 2.43M |
| ASEP Medical Holdings | 2.06M |